Loading...
OTCM
PAIYY
Market cap428kUSD
Jul 06, Last price  
0.01USD
IPO
-91.89%
Name

Aesthetic Medical International Holdings Group Ltd

Chart & Performance

D1W1MN
OTCM:PAIYY chart
P/E
P/S
0.01
EPS
Div Yield, %
Shrs. gr., 5y
17.08%
Rev. gr., 5y
-4.85%
Revenues
703m
-6.95%
584,857,000697,396,000761,306,000869,050,000901,573,000645,593,000670,091,000682,587,000755,671,000703,160,933
Net income
-52m
L+160.18%
50,350,000-76,675,000-255,237,000136,309,000-235,479,000-586,619,000-76,247,000-37,432,000-19,945,000-51,893,567
CFO
-16m
L
52,084,00076,979,0004,894,00086,761,000-843,00051,091,000-75,126,00074,286,00079,669,000-16,290,730

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aesthetic Medical International Holdings Group Limited operates as a specialist in diverse cosmetic medical services. The company's comprehensive portfolio features various surgical aesthetic procedures, such as ophthalmic surgery, rhinoplasty, breast enlargement, and liposuction. Additionally, it offers non-surgical aesthetic treatments, which encompass minimally invasive techniques and energy-based therapies like laser, ultrasound, and ultraviolet light applications. Beyond these, the group provides a broader range of general healthcare and other beauty-focused medical services, including internal medicine, urology, gynecology, obstetrics, dental care, dermatological treatments, and solutions for hair loss. With operations spanning 15 treatment centers, its facilities are located across China, Hong Kong, and Singapore. The enterprise was founded in 1997 and its main office is situated in Shenzhen, People's Republic of China.
IPO date
Oct 25, 2019
Employees
1,167
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT